Key points:
- The U.S. Court of Appeals for the Eleventh Circuit upheld the FDA’s denial of Bidi Vapor LLC’s application to market its tobacco-flavored e-cigarette.
- The court determined that the FDA’s decision was not arbitrary or capricious, emphasizing the agency’s thorough analysis of potential abuse liability.
- This ruling reinforces the FDA’s authority to regulate e-cigarette products, particularly concerning their appeal to youth and associated health risks.
The U.S. Court of Appeals for the Eleventh Circuit ruled on April 24 that the U.S. Food and Drug Administration lawfully denied Bidi Vapor LLC’s application to market its tobacco-flavored disposable e-cigarette, the Bidi Stick-Classic.
The court concluded that the FDA’s decision was neither arbitrary nor capricious, highlighting the agency’s “comprehensive evaluation” of the product’s potential for abuse and its impact on public health. The FDA’s analysis connected its findings to its decision to issue a Marketing Denial Order (MDO) for the product, according to the court.
Bidi Vapor had contended that the FDA’s denial was unjustified, arguing that the agency acknowledged adult smokers might switch to its product, which could be a less harmful than combustible cigarettes. However, the court found that the FDA’s concerns about the product’s appeal to youth and potential health risks were “well-founded.”
